International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Franck Pagès, Bernhard Mlecnik, Florence Marliot, +95

The Lancet

Prognostic BiomarkersOncologyInternational ValidationMedicineImmunology +10

Frequent EpCam protein expression in human carcinomas

Philip Went, Alessandro Lugli, Sandra Meier, +4

Human Pathology

Tumor BiologyPathologyTumor SuppressorMedicineCancer Research +2

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer

Raoul A. Droeser, Christian Hirt, Carsten T. Viehl, +19

European Journal of Cancer

Tumor BiologyMedicineApoptosisColorectal CancerCell Death +7

High frequency of tumor‐infiltrating FOXP3⁺ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

Daniel M. Frey, Raoul A. Droeser, Carsten T. Viehl, +7

International Journal of Cancer

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

Alessandro Lugli, Giandomenica Iezzi, Isabel C. Hostettler, +7

British Journal of Cancer

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

Inti Zlobec, Russell Steele, Luigi Terracciano, +2

Journal of Clinical Pathology

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

Bernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, +88

Journal of Clinical Oncology

Prevalence of KIT Expression in Human Tumors

Philip Went, Stephan Dirnhofer, Marcel Bundi, +8

Journal of Clinical Oncology

Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer

Pia Huusko, Damaris Ponciano‐Jackson, Maija Wolf, +23

Nature Genetics

UrologySomatic VariantMedicineCancer GenomicsProstatic Disease +6

Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?

Claude Fischer, Inti Zlobec, Edith Green, +6

International Journal of Cancer

P16 Negative OpsccTreatment ModalityPathologyHpv InfectionTumor Biology +15